Aptar Pharma Completes First Phase of Global Expansion Program to Meet Growing Customer Capacity Needs for Injectable Drug Delivery
Crystal Lake, Illinois, October 31, 2022 - Aptar Pharma, a global
leader in drug delivery systems, services and active material science
solutions, today announced that it has delivered the first phase of its
previously announced expansion program of approximately $180 million USD
to meet growing customer capacity needs for injection system solutions.
The multisite, international expansion project began in 2020 and is
intended to significantly boost capacity across all product lines,
ultimately enabling Aptar Pharma to produce over 10 billion injectable
component units annually when completed.
More info >> |